GlobeNewswire Inc.·Mar 14·Robbins Geller Rudman & Dowd LlpNavan Faces Securities Lawsuit Over Concealed Marketing Spending SurgeNavan investors sue over allegedly misleading IPO disclosures. Stock crashed 63% after surprise 39% sales expense hike revealed. NAVNsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Mar 14·Robbins Geller Rudman & Dowd LlpDriven Brands Faces Class Action Over $DRVN Financial Restatement; Stock Plummets 40%Driven Brands ($DRVN) faces class action lawsuit over accounting errors in fiscal 2023-2025 statements. Stock fell 40% after February disclosure. Investors can seek lead plaintiff status. DRVNsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Mar 13·Rosen Law FirmAmerica's Car-Mart Stock Plunges 18% After Surprise Loss; Securities Probe LaunchedAmerica's Car-Mart stock plunges 18% after reporting unexpected quarterly loss; securities investigation launched over alleged misleading disclosures. CRMTsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Mar 13·Rosen Law FirmNavan Hit With Securities Suit Over IPO Disclosure ClaimsClass action lawsuit filed against $NAAM alleges October 2025 IPO prospectus contained false statements about sales and marketing expenses. Lead plaintiff deadline: April 24, 2026. NAVNsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Mar 13·Rosen Law FirmEos Energy Investors Face May 2026 Deadline in Securities Class ActionRosen Law Firm pursues class action against Eos Energy Enterprises for alleged false statements about operations and guidance. Investors must act by May 5, 2026 deadline. SMREOSENKTRsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Mar 13·Bragar Eagel & Squire, P.C.ODDITY Tech Stock Crashes 49% After Disclosure of Hidden Ad Partner Algorithm ChangesODDITY Tech faces class action lawsuit alleging concealment of ad partner algorithm changes that inflated customer acquisition costs. Stock fell 49% after CEO disclosure on February 25. ODDsecurities fraudclass action lawsuit
Benzinga·Mar 13·Law Offices Of Howard G. SmithSoleno Therapeutics Faces Securities Fraud Suit Over DCCR Drug; Deadline LoomsSoleno Therapeutics ($SLNO) faces securities fraud lawsuit over DCCR drug for Prader-Willi syndrome. Stock plunged following safety concerns, patient death, and weak Q3 results. SLNOsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Mar 13·Rosen Law FirmClass Action Lawsuits Target Nektar, Enphase Over Alleged False StatementsRosen Law Firm files securities class actions against Nektar Therapeutics, Enphase Energy, and Aquestive Therapeutics. Investors have until May 5, 2026 to join. ENPHAQSTNKTRsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Mar 13·Rosen Law FirmClass Action Lawsuit Filed Against Aquestive Therapeutics Over Alleged Securities ViolationsRosen Law Firm filed class action against Aquestive Therapeutics alleging false statements about product development and regulatory matters. Eligible investors should act before deadline. ENPHAQSTNKTRsecurities fraudclass action lawsuit
Benzinga·Mar 13·The Law Offices Of Frank R. CruzPaysafe Faces Securities Fraud Lawsuit Over Undisclosed Client ExposureLaw firm files class action against $PSFE alleging disclosure failures on high-risk client exposure and credit reserves between March-November 2025. PSFEsecurities fraudclass action lawsuit
Benzinga·Mar 13·Law Offices Of Howard G. SmithDRVN Plummets 30% After Accounting Restatement; Class Action Deadline LoomsDriven Brands ($DRVN) stock plummets 30.2% after disclosing multi-year accounting errors. Class action deadline set for May 8, 2026. DRVNsecurities fraudclass action lawsuit
Benzinga·Mar 13·Law Offices Of Howard G. SmithCamping World Faces Securities Fraud Lawsuit Over Inventory and Demand MisstatementsClass action lawsuit filed against $CWH for allegedly making false statements about business operations. Stock fell 24.8% and 16.5% in two separate drops. CWHsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Mar 13·Bronstein, Gewirtz & Grossman LlcSecurities Fraud Lawsuit Filed Against Driven Brands Over Accounting ControlsLawsuit filed against Driven Brands for securities fraud, alleging material misstatements, failed accounting controls, and overstated revenue spanning 2023-2024. DRVNsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Mar 13·Bronstein, Gewirtz & Grossman LlcMereo BioPharma Faces Class Action Over Failed Clinical Trials and Investor LossesClass action lawsuit filed against Mereo BioPharma over alleged misstatements regarding failed Phase 3 clinical trials. Investors have until April 6, 2026, to join. MREOsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Mar 13·Bronstein, Gewirtz & Grossman LlcSnowflake Faces Class Action Over Undisclosed Efficiency Changes, CEO DepartureClass action lawsuit filed against Snowflake alleging executives misled investors about product efficiency improvements and pricing changes while concealing CEO resignation plans. SNOWsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Mar 13·Bronstein, Gewirtz & Grossman LlcSmart Digital Group Faces Class Action Over Market Manipulation, Insider Trading AllegationsSmart Digital Group faces class action lawsuit alleging market manipulation, insider trading, and fraudulent social media promotion. Lead plaintiff deadline March 16, 2026. SDMsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Mar 13·Bronstein, Gewirtz & Grossman LlcApollo Global Management Faces Class Action Over Epstein Ties, Investor ClaimsClass action lawsuit filed against $APO alleging leadership made false statements about Jeffrey Epstein business dealings. Eligible investors purchased securities between May 2021 and February 2026. APOAPOSAPOpAsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Mar 13·NaNektar Therapeutics Faces Class Action Over Misleading Trial Data ClaimsClass action lawsuit filed against $NKTX alleging executives made false statements about REZOLVE-AA trial enrollment protocols, potentially harming investor value. NKTRsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Mar 13·Bronstein, Gewirtz & Grossman LlcRamaco Resources Faces Class Action Over Alleged Brook Mine MisrepresentationsClass action lawsuit filed against $METC alleges executives made false statements about Brook Mine development progress. Investors from July-October 2025 urged to participate. METCMETCBMETCIMETCZsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Mar 13·Bronstein, Gewirtz & Grossman LlcCorcept Therapeutics Faces Class Action Over Relacorilant Clinical Trial ClaimsClass action lawsuit filed against $CORP alleging executives made false statements about relacorilant's clinical strength and FDA approval prospects. CORTsecurities fraudclass action lawsuit